You are here: Industry Insights > DBT

News List

Dr Jyotsna Dhawan joins DBT/India Alliance as CEO expresspharma
December 07, 2021
She has taken over responsibilities from Dr Vasan Sambandamurthy with effect from 1st December, 2021 till further communication
Facility augmentation of Bharat Biotech and three other PSEs being supported for augmented production of Covaxin: Health Minister expresspharma
August 09, 2021
CDSCO puts in place system to fast track processing of application for clinical trial and approval for COVID-19 vaccines.
India has huge resource material for research: Jitendra Singh expresspharma
July 13, 2021
COVID-19 provides opportunity to work on strategic research outcomes which are specifically India-centric, said the Union Minister.
Researchers at ILS Bhubaneshwar develop animal models to study coronavirus expresspharma
June 08, 2021
Animal models that closely resemble the pathogenesis of SARS-CoV-2-induced disease in humans are essential for research on disease mechanisms and for the evaluation of potential vaccines and antiviral drugs, the DBT said in a statement.
Scientific community rose to occasion when COVID-19 hit country: Vardhan expresspharma
March 02, 2021
The three-day event from March 1-3 will showcase the strength and opportunities of the India's biotechnology sector at national level and to the global community.
NIBEC, a DBT-supported facility for viral immunogenicity testing inaugurated in Pune expresspharma
September 07, 2020
Reportedly, the laboratory has already started associating closely with leading Indian vaccine manufacturing companies and national and international institutes engaged in vaccine developments.
Five sites in India ready for Oxford-AstraZeneca COVID-19 vaccine trial: DBT expresspharma
July 28, 2020
The vaccine is in its third phase of human trials, Serum Institute of India is partnering Oxford and AstraZeneca to manufacture the vaccine once it is ready.
DBT seed funds Gennova Biopharmaceuticals’ novel mRNA-based COVID-19 vaccine candidate expresspharma
July 27, 2020
DBT-BIRAC has facilitated the establishment of ‘first-of-its-kind’ mRNA-based vaccine manufacturing platform in India. It has provided seed funding for the development of Gennova’s novel self-amplifying mRNA-based vaccine candidate for COVID19.
DBT establishes four COVID-19 bio banks expresspharma
June 01, 2020
Oropharyngeal/nasopharyngeal swabs, bronchoalveolar lavage, sputum, blood, urine and stool of COVID19 patients will be collected and archived at these biobanks for future use to develop validated diagnostics, therapeutics, vaccines etc.
DBT-BIRAC COVID-19 research consortium recommends 70 proposals for funding in vaccines, diagnostics, expresspharma
May 12, 2020
The shortlisted proposals includes10 vaccines candidates, 34 diagnostics products or scale-up facilities, 10 therapeutics options, two proposals on drug repurposing and 14 projects which are categorised as preventive interventions.

Previous page 1 2 Next page